Published in PLoS One on March 07, 2017
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70
Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med (1966) 8.63
III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis (2001) 4.18
The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant (2007) 2.13
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis (2006) 2.09
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant (2002) 2.05
Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol (2002) 2.03
The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol (2001) 1.76
C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int (1998) 1.73
Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant (2004) 1.30
C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum (1992) 1.29
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2005) 1.21
Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke (2005) 1.20
The role of interleukin-6 in the failing heart. Heart Fail Rev (2001) 1.10
Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis (2002) 1.05
Change in access blood flow over time predicts vascular access thrombosis. Kidney Int (1998) 1.03
Stretch-induced IL-6 secretion from endothelial cells requires NF-kappaB activation. Biochem Biophys Res Commun (2003) 0.93
Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis (2002) 0.90
Patient-specific computational modeling of upper extremity arteriovenous fistula creation: its feasibility to support clinical decision-making. PLoS One (2012) 0.86
Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. Am J Kidney Dis (2002) 0.86
Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J (2005) 0.85
Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis (1998) 0.85
Discrepancy of interleukin-6 levels between end-stage renal disease patients and patients with acute-phase response with increased lipoprotein(a) concentrations. Scand J Clin Lab Invest (2004) 0.81
Higher arteriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int (2009) 0.81
The microinflammatory state of uremia. Blood Purif (2000) 0.80
Cardiovascular remodeling after AVF surgery in rats assessed by a clinical MRI scanner. Magn Reson Imaging (2010) 0.77
Moderator's view: a 'secular' view on vascular access in haemodialysis. Nephrol Dial Transplant (2012) 0.77
[The study of cause of early death and a matched study for the risk factors in patients undergoing maintenance hemodialysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue (2015) 0.77